2020-03-09
Optimeos Life Sciences, a startup established by two Princeton University faculty members in 2016 with the aim of developing innovative nanoparticle-based approaches for the sustained delivery of therapeutic agents, has lately signed agreements with six pharmaceutical companies to transfer its proprietary technology, called flash nanoprecipitation, from lab to market for enhancing the efficacy...
